$KNDI Company News Charting the S&P 500’s bearish

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Container Store Group's NYSE Delisting Announcement The New York Stock Exchange (NYSE) has made a significant announcement regarding the trading status of The Container Store Group, Inc. (TCS). The Exchange's staff has determined that it will initiate proceedings to delist the Company's common stock. This decision comes in light of the Company's recent performance in the...

Investing in the Vanguard Russell 2000 ETF: A Strategic Approach In recent years, the stock market's performance has been largely driven by large corporations. While megacap tech stocks have thrived, small-cap stocks have struggled to keep pace. This has resulted in significant valuation discounts for smaller companies compared to their larger peers. Over the past five...

Ann Dunkin Joins Our Board of Directors We are thrilled to announce the appointment of Ann Dunkin, P.E., to our Board of Directors. With an extensive background in engineering and a strong commitment to public service, Ann's diverse expertise will be invaluable as we navigate the challenges and opportunities in our industry. Professional Background of Ann Dunkin Ann...

Understanding Management Trading Activities When assessing a company's health and future prospects, observing management trading can provide invaluable insights. Executive transactions—buying or selling shares—often reflect their confidence in the business's performance. An increase in stock purchases by management usually signals optimism, while significant sales may...

Breakthrough Findings in Biliary Tract Cancer Treatment Compass Therapeutics, Inc. has announced promising interim results from their ongoing Phase 2/3 study, COMPANION-002, examining the efficacy of tovecimig, formerly known as CTX-009, in combination with paclitaxel for treating advanced biliary tract cancer (BTC). Tovecimig, a bispecific antibody targeting both DLL4...